-
1
-
-
0027087331
-
Costimulation of T lymphocytes: The role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy
-
Schwartz RH. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 1992; 71: 1065.
-
(1992)
Cell
, vol.71
, pp. 1065
-
-
Schwartz, R.H.1
-
2
-
-
0027942023
-
Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity
-
Guinan EC, Gribben JG, Boussiotis VA, Freeman GJ, Nadler LM. Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity. Blood 1994; 84: 3261.
-
(1994)
Blood
, vol.84
, pp. 3261
-
-
Guinan, E.C.1
Gribben, J.G.2
Boussiotis, V.A.3
Freeman, G.J.4
Nadler, L.M.5
-
4
-
-
0025830902
-
CTLA-4 is a second receptor for the B cell activation antigen B7
-
Linsley PS, Brady W, Urnes M, Grosmaire LS, Damle NK, Ledbetter JA. CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med 1991; 174: 561.
-
(1991)
J Exp Med
, vol.174
, pp. 561
-
-
Linsley, P.S.1
Brady, W.2
Urnes, M.3
Grosmaire, L.S.4
Damle, N.K.5
Ledbetter, J.A.6
-
5
-
-
0029899783
-
CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells
-
Krummel MF, Allison JP. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J Exp Med 1996; 183: 2533.
-
(1996)
J Exp Med
, vol.183
, pp. 2533
-
-
Krummel, M.F.1
Allison, J.P.2
-
6
-
-
0029953858
-
CTLA-4 ligation blocks CD28-dependent T cell activation
-
Walunas TL, Bakker CY, Bluestone JA. CTLA-4 ligation blocks CD28-dependent T cell activation. J Exp Med 1996; 183: 2541.
-
(1996)
J Exp Med
, vol.183
, pp. 2541
-
-
Walunas, T.L.1
Bakker, C.Y.2
Bluestone, J.A.3
-
7
-
-
0028867420
-
Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4
-
Tivol EA, Boriello F, Schweitzer AN, Lynch WP, Bluestone JA, Sharpe AH. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 1995; 3: 541.
-
(1995)
Immunity
, vol.3
, pp. 541
-
-
Tivol, E.A.1
Boriello, F.2
Schweitzer, A.N.3
Lynch, W.P.4
Bluestone, J.A.5
Sharpe, A.H.6
-
8
-
-
0028791059
-
Lymphoproliferative disorders with early lethality in mice deficient in CTLA4
-
Waterhouse P, Penninger JM, Timms E, et al. Lymphoproliferative disorders with early lethality in mice deficient in CTLA4. Science 1995; 270: 985.
-
(1995)
Science
, vol.270
, pp. 985
-
-
Waterhouse, P.1
Penninger, J.M.2
Timms, E.3
-
9
-
-
0028886953
-
T cell costimulatory pathways: Promising novel targets for immunosuppression and tolerance induction
-
Sayegh MH, Turka LA. T cell costimulatory pathways: promising novel targets for immunosuppression and tolerance induction. J Am Soc Nephrol 1995; 6: 1143.
-
(1995)
J Am Soc Nephrol
, vol.6
, pp. 1143
-
-
Sayegh, M.H.1
Turka, L.A.2
-
10
-
-
0027451441
-
Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion
-
Lin H, Bolling SF, Linsley PS, et al. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion. J Exp Med 1993; 178: 1801.
-
(1993)
J Exp Med
, vol.178
, pp. 1801
-
-
Lin, H.1
Bolling, S.F.2
Linsley, P.S.3
-
11
-
-
0029944669
-
CTLA4-Ig plus bone marrow induces long-term allograft survival and donor-specific unresponsiveness in the murine model
-
Pearson TC, Alexander DZ, Hendrix R, et al. CTLA4-Ig plus bone marrow induces long-term allograft survival and donor-specific unresponsiveness in the murine model. Transplantation 1996; 61: 997.
-
(1996)
Transplantation
, vol.61
, pp. 997
-
-
Pearson, T.C.1
Alexander, D.Z.2
Hendrix, R.3
-
13
-
-
0029122983
-
Ex vivo coating of islet cell allografts with murine CTLA4/Fc promotes graft tolerance
-
Steurer W, Nickerson PW, Steele AW, Steiger J, Zheng XX, Strom TB. Ex vivo coating of islet cell allografts with murine CTLA4/Fc promotes graft tolerance. J Immunol 1995; 155: 1165.
-
(1995)
J Immunol
, vol.155
, pp. 1165
-
-
Steurer, W.1
Nickerson, P.W.2
Steele, A.W.3
Steiger, J.4
Zheng, X.X.5
Strom, T.B.6
-
14
-
-
0030587810
-
Ex-vivo treatment of antigen presenting cells with CTLA4Ig and encephalitogenic peptide prevents experimental autoimmune encephalomyelitis in the Lewis rat
-
Khoury SJ, Gallon L, Verburg RR, et al. Ex-vivo treatment of antigen presenting cells with CTLA4Ig and encephalitogenic peptide prevents experimental autoimmune encephalomyelitis in the Lewis rat. J Immunol 1996; 157: 3700.
-
(1996)
J Immunol
, vol.157
, pp. 3700
-
-
Khoury, S.J.1
Gallon, L.2
Verburg, R.R.3
-
15
-
-
0026559329
-
Cells that present both specific ligand and costimulatory activity are the most efficient inducers of clonal expansion of normal CD4 T cells
-
Liu Y, Janeway CA. Cells that present both specific ligand and costimulatory activity are the most efficient inducers of clonal expansion of normal CD4 T cells. Proc Natl Acad Sci USA 1992; 89: 3845.
-
(1992)
Proc Natl Acad Sci USA
, vol.89
, pp. 3845
-
-
Liu, Y.1
Janeway, C.A.2
-
16
-
-
0026545914
-
Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection
-
Benichou G, Takizawa PA, Olson CA, McMillan M, Sercarz EE. Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection. J Exp Med 1992; 175: 305.
-
(1992)
J Exp Med
, vol.175
, pp. 305
-
-
Benichou, G.1
Takizawa, P.A.2
Olson, C.A.3
McMillan, M.4
Sercarz, E.E.5
-
17
-
-
0026566079
-
Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides
-
Fangmann J, Dalchau R, Fabre JW. Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides. J Exp Med 1992; 175: 1521.
-
(1992)
J Exp Med
, vol.175
, pp. 1521
-
-
Fangmann, J.1
Dalchau, R.2
Fabre, J.W.3
-
18
-
-
0028176656
-
Indirect presentation of MHC antigens in transplantation
-
Shoskes DA, Wood KJ. Indirect presentation of MHC antigens in transplantation. Immunol Today 1994; 15: 32.
-
(1994)
Immunol Today
, vol.15
, pp. 32
-
-
Shoskes, D.A.1
Wood, K.J.2
-
19
-
-
9544241307
-
Indirect recognition of donor HLA peptides in organ allograft rejection
-
Liu Z, Colovai AI, Tuguloa S, et al. Indirect recognition of donor HLA peptides in organ allograft rejection. J Clin Invest 1996; 98: 1150.
-
(1996)
J Clin Invest
, vol.98
, pp. 1150
-
-
Liu, Z.1
Colovai, A.I.2
Tuguloa, S.3
-
20
-
-
0029688680
-
Role of indirect allorecognition in allograft rejection
-
Sayegh MH, Carpenter CB. Role of indirect allorecognition in allograft rejection. Int Rev Immunol 1996; 13: 221.
-
(1996)
Int Rev Immunol
, vol.13
, pp. 221
-
-
Sayegh, M.H.1
Carpenter, C.B.2
-
21
-
-
0027538467
-
The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice
-
Auchincloss H Jr, Lee R, Shea S, Markowitz JS, Grusby MJ, Glimcher LH. The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. Proc Natl Acad Sci USA 1993; 90: 3373.
-
(1993)
Proc Natl Acad Sci USA
, vol.90
, pp. 3373
-
-
Auchincloss H., Jr.1
Lee, R.2
Shea, S.3
Markowitz, J.S.4
Grusby, M.J.5
Glimcher, L.H.6
-
22
-
-
0028031970
-
Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo
-
Lee RS, Grusby ML, Glimcher LH, Winn HJ, Auchincloss H Jr. Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo. J Exp Med 1994; 179: 865.
-
(1994)
J Exp Med
, vol.179
, pp. 865
-
-
Lee, R.S.1
Grusby, M.L.2
Glimcher, L.H.3
Winn, H.J.4
Auchincloss H., Jr.5
-
23
-
-
0027195156
-
Donor cell chimerism permitted by immunosuppressive drugs: A new view of organ transplantation
-
Starzl TE, Demetris AJ, Murase N, Thomson AW, Trucco M, Ricordi C. Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. Immunol Today 1993; 14: 326.
-
(1993)
Immunol Today
, vol.14
, pp. 326
-
-
Starzl, T.E.1
Demetris, A.J.2
Murase, N.3
Thomson, A.W.4
Trucco, M.5
Ricordi, C.6
-
24
-
-
0029047240
-
Donor-recipient microchimerism is not required for tolerance induction following recipient pretreatment with anti-CD4 antibody: Evidence of a clear role for short-term antigen-persistence
-
Bushell A, Pearson TC, Morris PJ, Wood KJ. Donor-recipient microchimerism is not required for tolerance induction following recipient pretreatment with anti-CD4 antibody: evidence of a clear role for short-term antigen-persistence. Transplantation 1995; 59: 1367.
-
(1995)
Transplantation
, vol.59
, pp. 1367
-
-
Bushell, A.1
Pearson, T.C.2
Morris, P.J.3
Wood, K.J.4
-
25
-
-
0028903939
-
CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2
-
Sayegh MH, Akalin E, Hancock WW, Russell ME, Carpenter CB, Turka LA. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med 1995; 181: 1869.
-
(1995)
J Exp Med
, vol.181
, pp. 1869
-
-
Sayegh, M.H.1
Akalin, E.2
Hancock, W.W.3
Russell, M.E.4
Carpenter, C.B.5
Turka, L.A.6
|